Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Latest filing published 23 Sept 2026 for OnKure Therapeutics, Inc., €225.
Filing timeline
BuySaleNicholas A. Saccomano
Insider track record
Disclosed buys
0
Disclosed sells
8
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Nicholas A. Saccomano: trading record in brief
Nicholas A. Saccomano has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Array Biopharma Inc and OnKure Therapeutics, Inc. Over a trading history stretching from 1 April 2016 to 21 September 2026, the count stands at 29 filings.
No open-market purchase appears, only 8 sales worth €3.6M. The rest of the record consists of 10 share grants and 9 option exercises. 2026 to date brings no purchases and 2 sales.
Most recently, on 23 September 2026, the filings show an open-market sale worth €225 in OnKure Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Nicholas A. Saccomano
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
87 shares@ US$2.9742Class A Common StockSEC:0001609284-26-000005:0
86 shares@ US$4.156519.7% of flowClass A Common StockSEC:0001609284-26-000001:0
87 shares@ US$2.967711.1% of flowClass A Common StockSEC:0001609284-25-000004:0
88 shares@ US$2.623511.1% of flowClass A Common StockSEC:0001609284-25-000003:0
88 shares@ US$2.384214.4% of flowClass A Common StockSEC:0001415889-25-018235:0
358 shares@ US$3.3276100.0% of flowClass A Common StockSEC:0001415889-25-010419:0
4,556 sharesClass A Common StockSEC:0001415889-24-024921:0
7 of 7 declarations
